isosorbide dinitrate has been researched along with Hematochezia in 59 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 12 (20.34) | 18.2507 |
2000's | 36 (61.02) | 29.6817 |
2010's | 11 (18.64) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, SL; Chen, YP; Fan, YC; Ling, XF; Liu, WY; Pan, ZZ; Shi, KQ; Zheng, MH | 1 |
Chen, C; Hao, JH; Kong, DR; Li, P; Ma, C; Wang, JG; Wang, M; Xu, JM; Zhang, L | 1 |
Bai, M; Fan, D; Han, G; Qi, X; Yang, M | 1 |
Aracil, C; Colomo, A; Gich, I; Graupera, I; Guarner, C; Hernández-Gea, V; Poca, M; Puente, A; Roque, M; Villanueva, C | 1 |
Appenrodt, B; Caca, K; Dollinger, M; Fimmers, R; Hoffmeister, A; Lorenzen, H; Lutz, H; Mengel, M; Panther, E; Rössle, M; Sauerbruch, T; Schepke, M; Schoo, R; Trebicka, J; Wiest, R; Zipprich, A | 1 |
Alvarado, E; Aracil, C; Ardevol, A; Colomo, A; Concepción, M; Graupera, I; Guarner, C; Hernandez-Gea, V; Miñana, J; Pavel, O; Poca, M; Puente, Á; Reñe, JM; Torras, X; Villanueva, C | 1 |
Chan, HH; Chen, TA; Chen, WC; Hsu, PI; Lai, KH; Lin, CK; Lo, GH; Tsai, WL; Yu, HC | 1 |
Aracil, C; Balanzo, J; Colomo, A; Gonzalez, B; Guarner, C; Lopez-Balaguer, JM; Piqueras, M; Torras, X; Villanueva, C | 1 |
Abraldes, JG; Albillos, A; Bañares, R; Bosch, J; García-Pagán, JC; Morillas, R; Villanueva, C | 1 |
Kumar, A; Sarin, SK; Sharma, BC; Sharma, P | 1 |
Ahmad, I; Alam, A; Butt, AK; Khan, AA; Sarwar, S; Shafqat, F | 1 |
Dubey, S; Jha, SK; Kumar, A; Sarin, SK; Sharma, BC; Sharma, P; Tyagi, P | 1 |
Cheung, J; Tandon, P; van Zanten, SV; Zeman, M | 1 |
Schepke, M | 1 |
Kravetz, D | 1 |
Gluud, LL; Krag, A; Langholz, E | 1 |
Li, L; Li, Y; Yu, C | 1 |
Abu-Suboh, M; Armengol, JR; Augustin, S; Dot, J; Esteban, R; Genescà, J; González, A; Guardia, J; Pérez, M; Romero, A; Segarra, A | 1 |
Chen, WC; Lo, GH; Wang, HM; Yu, HC | 1 |
Lock, G; Messmann, H; Wiest, R | 1 |
Chen, GH; Wu, CY; Yeh, HZ | 1 |
Bissoli, F; Borroni, G; Cazzaniga, M; de Franchis, R; Lorenzano, E; Maggi, A; Panzeri, A; Salerno, F; Visentin, S | 1 |
Barkin, JS; Maldonado, D | 1 |
Chen, MH; Chen, WC; Hsu, PI; Lai, KH; Lin, CK; Lo, GH; Tsai, WL | 1 |
Finlayson, ND; Forrest, EH; Hayes, PC; Hislop, WS; Jalan, R; Lui, HF; Macgilchrist, AJ; Mills, PR; Stanley, AJ | 1 |
Alric, L; Barange, K; Bureau, C; Morales, J; Payen, JL; Péron, JM; Sanchez, J; Vinel, JP | 1 |
Fleig, WE | 1 |
Wang, H; Yuan, R; Zhang, Q | 1 |
Blendis, L; Lurie, Y; Oren, R | 1 |
Mann, NS | 1 |
Krishnan, A; Thuluvath, PJ | 1 |
Bhaskar, ME | 1 |
Gupta, R; Sarin, SK; Shahi, H; Wadhawan, M | 1 |
Balanzo, J; Cusso, X; Gallego, A; Gonzalez-Suarez, B; Guarner, C; Minana, J; Sainz, S; Soriano, G; Torras, X; Villanueva, C | 1 |
Garrido, A; Garzón, M; Grilo, I; Iglesias, A; Márquez, JL; Peiró, J | 1 |
Argonz, J; Bosco, A; Dominguez, N; Fassio, E; Kravetz, D; Muñoz, A; Romero, G; Salgado, P; Suarez, A; Terg, R; Vulcano, C | 1 |
Laleman, W; Nevens, F | 1 |
Chan, HH; Chen, WC; Cheng, LC; Hsu, PI; Lai, KH; Lo, GH; Tsai, WL; Wang, HM | 1 |
Capasso, F; Gaginella, TS; Izzo, AA; Mascolo, N | 1 |
Bangash, IH; Finlayson, ND; Hayes, PC; Jones, AL; Simpson, KJ; Walker, J | 1 |
Beltrami, M; Bertoni, G; Briglia, R; Conigliaro, R; Fornaciari, G; Grisendi, A; Pacchione, D; Pedretti, G; Sassatelli, R; Tansini, P | 1 |
Abbati, G; Cioni, G; Cristani, A; D'Alimonte, P; Romagnoli, R; Tincani, E; Ventura, E; Ventura, P; Vignoli, A | 1 |
Fassio, E; Fernández, N; Landeira, G; Longo, C; Viudez, P | 1 |
Hayes, PC; Jones, AL | 1 |
Angelico, M; Bologna, E; Capocaccia, L; Carli, L; Gentile, S; Piat, C; Rinaldi, V | 1 |
Balanzó, J; Cussó, X; Guarner, C; Novella, MT; Sáinz, S; Soriano, G; Torras, X; Vilardell, F; Villanueva, C | 1 |
Chambliss, ML; Stevermer, JJ | 1 |
Angelico, M; Capocaccia, L; Carli, L; Gentile, S; Piat, C | 1 |
Lebrec, D | 1 |
Armengol, JR; Esteban, R; Junquera, F; López-Talavera, JC; Malagelada, JR; Mearin, F; Saperas, E; Videla, S | 1 |
Amodio, P; Bolognesi, M; Cavallarin, G; Donada, C; Felder, M; Gatta, A; Marin, R; Mazzaro, C; Merkel, C; Sacerdoti, D; Sebastianelli, G; Torboli, P | 1 |
Bosch, J | 1 |
Galmiche, JP; Gournay, J; Martin, T; Masliah, C; Perrin, D | 1 |
Herrera, JL; Zalepuga, R | 1 |
Abdurakhmanov, DT | 1 |
Wilkinson, ML; Wong, T | 1 |
Balanzó, J; Boadas, J; Cussó, X; Gallego, A; Guarner, C; Miñana, J; Ortiz, J; Sáinz, S; Soriano, G; Torras, X; Villanueva, C | 1 |
Landmark, K | 1 |
Cervinka, J; Drazná, E; Jedlicka, J; Petrtýl, J; Vrana, J | 1 |
12 review(s) available for isosorbide dinitrate and Hematochezia
Article | Year |
---|---|
Secondary prophylaxis of variceal bleeding for cirrhotic patients: a multiple-treatments meta-analysis.
Topics: Adrenergic beta-Antagonists; Combined Modality Therapy; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Laser Coagulation; Ligation; Liver Cirrhosis; Portasystemic Shunt, Transjugular Intrahepatic; Randomized Controlled Trials as Topic; Sclerotherapy; Secondary Prevention; Treatment Outcome; Vasodilator Agents | 2013 |
Combined therapies versus monotherapies for the first variceal bleeding in patients with high-risk varices: a meta-analysis of randomized controlled trials.
Topics: Combined Modality Therapy; Databases, Bibliographic; Drug Therapy, Combination; Endpoint Determination; Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Isosorbide Dinitrate; Nadolol; Propranolol; Randomized Controlled Trials as Topic; Risk; Spironolactone | 2014 |
Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review.
Topics: Adrenergic beta-Antagonists; Animals; Chi-Square Distribution; Combined Modality Therapy; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemostatic Techniques; Hemostatics; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Odds Ratio; Recurrence; Risk Factors; Treatment Outcome | 2014 |
Systematic review: secondary prevention with band ligation, pharmacotherapy or combination therapy after bleeding from oesophageal varices.
Topics: Adrenergic beta-Antagonists; Combined Modality Therapy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Randomized Controlled Trials as Topic; Secondary Prevention; Treatment Outcome; Vasodilator Agents | 2009 |
[Importance of drug treatment to lower portal pressure in the therapy of variceal bleeding].
Topics: Adrenergic beta-Antagonists; Anti-Bacterial Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Hormones; Humans; Hypertension, Portal; Infection Control; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Lypressin; Portal Pressure; Secondary Prevention; Somatostatin; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents | 2009 |
Meta-analysis: isosorbide-mononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices.
Topics: Adrenergic beta-Antagonists; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Randomized Controlled Trials as Topic; Statistics as Topic; Treatment Outcome; Vasodilator Agents | 2010 |
Endoscopic band ligation versus pharmacological therapy for variceal bleeding in cirrhosis: a meta-analysis.
Topics: Adrenergic beta-Antagonists; Comparative Effectiveness Research; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Primary Prevention; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Treatment Outcome; Vasodilator Agents | 2011 |
Primary prophylaxis of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Cost-Benefit Analysis; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Markov Chains; Portasystemic Shunt, Transjugular Intrahepatic; Risk Factors; Sclerotherapy; Vasodilator Agents | 2003 |
Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Animals; Contraindications; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Follow-Up Studies; Forecasting; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Middle Aged; Nadolol; Portasystemic Shunt, Surgical; Portasystemic Shunt, Transjugular Intrahepatic; Practice Guidelines as Topic; Propranolol; Randomized Controlled Trials as Topic; Rats; Risk Factors; Risk Reduction Behavior; Splanchnic Circulation; Stents; Time Factors; Vascular Resistance; Vasodilator Agents | 2006 |
Organic nitrates in portal hypertension.
Topics: Animals; Collateral Circulation; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Circulation; Liver Cirrhosis; Nitrates; Nitroglycerin; Vasodilator Agents | 1994 |
Medical decompressive therapy for prophylaxis of rebleeding.
Topics: Adrenergic beta-Antagonists; Combined Modality Therapy; Controlled Clinical Trials as Topic; Delayed-Action Preparations; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Recurrence; Sclerotherapy; Vasodilator Agents | 1998 |
The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Transplantation; Lypressin; Middle Aged; Mineralocorticoid Receptor Antagonists; Nadolol; Nitric Oxide Donors; Nitroglycerin; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Randomized Controlled Trials as Topic; Recurrence; Sclerotherapy; Spironolactone; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
31 trial(s) available for isosorbide dinitrate and Hematochezia
Article | Year |
---|---|
Effects of propranolol or propranolol plus isosorbide-5-mononitrate on variceal pressure in schistosomiasis.
Topics: Adult; China; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Male; Middle Aged; Portal Pressure; Propranolol; Schistosomiasis; Time Factors; Treatment Outcome; Vasodilator Agents | 2013 |
Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Germany; Humans; Isosorbide Dinitrate; Kaplan-Meier Estimate; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide Donors; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Prospective Studies; Prosthesis Design; Quality of Life; Recurrence; Stents; Time Factors; Treatment Outcome; Vasodilator Agents; Venous Pressure | 2015 |
A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Portal Pressure; Recurrence; Spain | 2017 |
Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Digestive System Surgical Procedures; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Kaplan-Meier Estimate; Ligation; Male; Middle Aged; Nadolol; Secondary Prevention; Treatment Outcome; Vasodilator Agents | 2008 |
Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Secondary Prevention; Venous Pressure | 2009 |
Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Combined Modality Therapy; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Prospective Studies; Secondary Prevention; Survival Analysis; Treatment Outcome; Vasodilator Agents | 2009 |
Propranolol, isosorbide mononitrate and endoscopic band ligation - alone or in varying combinations for the prevention of esophageal variceal rebleeding.
Topics: Adult; Aged; Combined Modality Therapy; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Middle Aged; Propranolol; Secondary Prevention; Vasodilator Agents; Young Adult | 2009 |
Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence.
Topics: Adult; Combined Modality Therapy; Endoscopy, Digestive System; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Circulation; Male; Propranolol; Risk Factors; Secondary Prevention; Vasodilator Agents; Venous Pressure | 2009 |
Adding banding ligation is effective as rescue therapy to prevent variceal rebleeding in haemodynamic non-responders to pharmacological therapy.
Topics: Acute Disease; Aged; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Secondary Prevention; Somatostatin; Treatment Outcome | 2012 |
Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Chi-Square Distribution; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Humans; Hypertension, Portal; Isosorbide Dinitrate; Kaplan-Meier Estimate; Ligation; Male; Middle Aged; Nadolol; Propanolamines; Proportional Hazards Models; Secondary Prevention; Vasodilator Agents | 2012 |
Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ascites; Blood Pressure; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Heart Rate; Humans; Isosorbide Dinitrate; Kidney; Liver Cirrhosis; Male; Middle Aged; Nadolol; Survival Rate; Treatment Outcome; Vasodilator Agents | 2002 |
Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding.
Topics: Adult; Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Secondary Prevention; Treatment Failure; Vasodilator Agents | 2002 |
Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Prognosis; Propranolol; Secondary Prevention; Vasodilator Agents | 2002 |
"A La Carte" treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding.
Topics: Adult; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Male; Middle Aged; Propranolol; Secondary Prevention; Treatment Outcome; Vasodilator Agents; Venous Pressure | 2002 |
[The randomized controlled trial of isosorbide mononitrate plus propranolol compared with propranolol alone for the prevention of variceal rebleeding].
Topics: Adult; Dizziness; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Headache; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Propranolol; Treatment Outcome; Vasodilator Agents | 2002 |
Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients.
Topics: Adult; Antihypertensive Agents; Drug Therapy, Combination; Endoscopy, Digestive System; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Propranolol; Secondary Prevention; Vasodilator Agents | 2005 |
Pharmacologic treatment of portal hypertension in the prevention of community-acquired spontaneous bacterial peritonitis.
Topics: Adrenergic beta-Antagonists; Bacterial Infections; Community-Acquired Infections; Drug Therapy, Combination; Epidemiologic Methods; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Peritonitis; Sclerotherapy; Secondary Prevention; Vasodilator Agents | 2006 |
Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial.
Topics: Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Sclerotherapy; Secondary Prevention | 2006 |
Comparison of endoscopic variceal ligation and nadolol plus isosorbide-5-mononitrate in the prevention of first variceal bleeding in cirrhotic patients.
Topics: Adult; Aged; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol | 2006 |
Portal and systemic haemodynamic response to acute and chronic administration of low and high dose isosorbide-5-mononitrate in patients with cirrhosis.
Topics: Adult; Aged; Azygos Vein; Blood Pressure; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Heart Rate; Hemodynamics; Humans; Isosorbide Dinitrate; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Patient Compliance; Regional Blood Flow; Stimulation, Chemical; Vasodilator Agents | 1995 |
Oral isosorbide-5-mononitrate reduces the rebleeding rate during the course of injection sclerotherapy for esophageal varices.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Male; Middle Aged; Recurrence; Sclerotherapy | 1994 |
Duplex Doppler ultrasonographic comparison of the effects of propranolol and isosorbide-5-mononitrate on portal hemodynamics.
Topics: Delayed-Action Preparations; Double-Blind Method; Drug Monitoring; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Propranolol; Splanchnic Circulation; Ultrasonography | 1993 |
[Isosorbide-5-mononitrate in the prevention of digestive hemorrhage in cirrhosis: randomized study].
Topics: Adult; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Male | 1993 |
Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis.
Topics: Aged; Digestive System; Endoscopy; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Patient Dropouts; Personnel Selection; Propranolol; Prospective Studies | 1993 |
Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nadolol; Recurrence; Sclerotherapy; Survival Analysis; Treatment Outcome; Vasodilator Agents | 1996 |
Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Propranolol; Single-Blind Method; Vasodilator Agents | 1997 |
Somatostatin plus isosorbide 5-mononitrate versus somatostatin in the control of acute gastro-oesophageal variceal bleeding: a double blind, randomised, placebo controlled clinical trial.
Topics: Acute Disease; Aged; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Male; Middle Aged; Somatostatin; Vasodilator Agents | 2000 |
Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ascites; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Randomized Controlled Trials as Topic | 2000 |
Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding.
Topics: Adrenergic beta-Antagonists; Aged; Drug Synergism; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Propranolol; Secondary Prevention; Survival Analysis; Vasodilator Agents | 2000 |
Should nitrates be used with beta blockers to prevent variceal bleeding?
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Nadolol; Vasodilator Agents | 2000 |
Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Postoperative Complications; Regression Analysis; Secondary Prevention; Survival Analysis; Vasodilator Agents | 2001 |
16 other study(ies) available for isosorbide dinitrate and Hematochezia
Article | Year |
---|---|
Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Propranolol; Risk Factors; Treatment Outcome; Vasodilator Agents; Young Adult | 2009 |
Gastrointestinal bleeding: Secondary prophylaxis for variceal bleeding.
Topics: Adrenergic beta-Antagonists; Delayed-Action Preparations; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Gastroplasty; Humans; Isosorbide Dinitrate; Nitric Oxide Donors; Portasystemic Shunt, Transjugular Intrahepatic; Sclerotherapy; Secondary Prevention; Treatment Outcome | 2010 |
[Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding].
Topics: Drug Therapy, Combination; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Nadolol; Randomized Controlled Trials as Topic; Recurrence | 2002 |
Pharmacologic efficacy in gastric variceal rebleeding and survival: including multivariate analysis.
Topics: Adrenergic beta-Antagonists; Carcinoma, Hepatocellular; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Portal Vein; Prognosis; Propranolol; Retrospective Studies; Risk Factors; Secondary Prevention; Survival Analysis; Venous Thrombosis | 2002 |
Combined therapy for secondary prophylaxis of variceal rebleeding?
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Isosorbide Dinitrate; Ligation; Nadolol; Postoperative Complications; Randomized Controlled Trials as Topic; Recurrence; Survival Analysis; Vasodilator Agents | 2002 |
[Therapy of portal hypertension].
Topics: Adrenergic beta-Antagonists; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Secondary Prevention; Survival Rate | 2002 |
"A la carte" treatment of portal hypertension or just "hors d'oeuvres".
Topics: Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Losartan; Prazosin; Propranolol | 2003 |
Optimal use of propranolol.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Propranolol | 2003 |
Management of cirrhosis and ascites.
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Nadolol; Propranolol; Secondary Prevention; Vasodilator Agents | 2004 |
[Hemorrhage due to peristomal ectopic varices: an infrequent complication of portal hypertension].
Topics: Cecal Neoplasms; Colonic Neoplasms; Diabetes Mellitus, Type 2; Duodenal Ulcer; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Ileostomy; Isosorbide Dinitrate; Male; Middle Aged; Peptic Ulcer Hemorrhage; Postoperative Complications; Propranolol; Surgical Stomas; Varicose Veins | 2006 |
Dissociation of castor oil-induced diarrhoea and intestinal mucosal injury in rat: effect of NG-nitro-L-arginine methyl ester.
Topics: Acid Phosphatase; Animals; Arginine; Castor Oil; Diarrhea; Dose-Response Relationship, Drug; Gastrointestinal Hemorrhage; Intestinal Mucosa; Isosorbide Dinitrate; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Vasodilator Agents | 1994 |
Prevention of variceal rebleeding.
Topics: Acute Disease; Adrenergic beta-Antagonists; Diuretics, Osmotic; Drug Combinations; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Nadolol; Randomized Controlled Trials as Topic; Recurrence; Reproducibility of Results; Sclerotherapy; Treatment Outcome | 1996 |
[Isosorbide-5-mononitrate (mono mac) in the prevention of bleeding from esophageal varicose veins in patients with liver cirrhosis].
Topics: Adrenergic beta-Antagonists; Blood Pressure; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Treatment Outcome; Vasodilator Agents | 2001 |
Somatostatin plus isosorbide mononitrate versus somatostatin in the control of acute gastro-oesophageal variceal bleeding: a double blind, randomised, placebo controlled trial.
Topics: Double-Blind Method; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hormones; Humans; Isosorbide Dinitrate; Middle Aged; Randomized Controlled Trials as Topic; Somatostatin; Vasodilator Agents | 2001 |
[Do nitrates reduce the risk of drug induced hemorrhage of the upper gastrointestinal tract?].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Nitrates; Risk Factors | 2001 |
[Endoscopic sclerotization of esophageal varices and nitrates in the treatment of portal hypertension with bleeding esophageal varices].
Topics: Blood Pressure; Combined Modality Therapy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Sclerotherapy | 1991 |